8-K: CIMG Secures Conditional Nasdaq Listing Extension

CIMG Inc. received conditional approval from the Nasdaq Hearings Panel to continue its listing, requiring compliance with periodic filing and equity rules by September 30, 2025.

Summary

• CIMG Inc. received a written notification from the Nasdaq Hearings Panel on September 2, 2025, granting its request for continued listing on The Nasdaq Stock Market.
• The Company had a hearing on August 14, 2025, regarding non-compliance with Nasdaq Listing Rules 5550(a)(2) (Bid Price Rule), 5250(c)(1) (Periodic Filing Rule), and 5550(b)(1) (Equity Rule).
• Continued listing is subject to CIMG Inc. regaining compliance with the Periodic Filing Rule by September 30, 2025.
• CIMG Inc. must also demonstrate compliance with the Equity Rule by September 30, 2025.
• The Company's compliance plan presented to the Panel included current and future capital raises and new revenue-raising contracts.
• During the exception period, CIMG Inc. must promptly notify Nasdaq of any significant events affecting its compliance.
• The Nasdaq Listing and Hearing Review Council may review the Panel's decision within 45 calendar days.

Sentiment

Score: 6

Explanation: While the company avoided immediate delisting, it remains under strict conditions and faces significant risks if it fails to meet the compliance deadlines. The need for capital raises indicates ongoing financial challenges.

Positives

• Nasdaq Hearings Panel granted CIMG Inc.'s request for continued listing, avoiding immediate delisting.
• The Company has a clear path and specific deadlines (September 30, 2025) to regain compliance with two key listing rules.

Negatives

• CIMG Inc. was previously non-compliant with three Nasdaq Listing Rules: Bid Price, Periodic Filing, and Equity.
• The continued listing is conditional, requiring the Company to meet specific compliance deadlines.
• The Nasdaq Listing and Hearing Review Council retains the right to review and potentially modify or reverse the Panel's decision within 45 days.

Risks

• No assurance that Nasdaq will accept the Company's plan to regain compliance.
• No assurance that the Company will regain compliance with the Listing Rules during the compliance period or in the future.
• No assurance that the Company will otherwise meet Nasdaq continued listing standards.
• No assurance that Nasdaq will grant the Company any relief from delisting as necessary.
• No assurance that the Company can ultimately meet applicable Nasdaq requirements for any such relief.
• Actual actions or events could differ materially from forward-looking statements.

Future Outlook

CIMG Inc. plans to regain compliance with Nasdaq listing rules through current and future capital raises and new revenue-raising contracts. However, there is no assurance that the Company will successfully implement its plan, regain compliance, or avoid delisting.

Management Comments

• The Company's compliance plan entailed current and future capital raises and new revenue raising contracts.

Industry Context

This event highlights the ongoing scrutiny by Nasdaq on listed companies to maintain compliance with listing standards, particularly concerning financial reporting and equity requirements. Companies facing similar challenges often propose capital raises and strategic revenue initiatives to address deficiencies, a common approach in the small-cap market.

Stakeholder Impact

• Shareholders: Potential positive impact from avoiding immediate delisting, but continued uncertainty and risk if compliance conditions are not met. Potential dilution from future capital raises.
• Employees: Continued stability of employment due to maintained listing, but underlying financial challenges persist.
• Creditors: May view the conditional listing as a positive step towards stability, but will monitor compliance efforts and capital raise success.

Next Steps

• CIMG Inc. must regain compliance with the Periodic Filing Rule by September 30, 2025.
• CIMG Inc. must demonstrate compliance with the Equity Rule by September 30, 2025.
• CIMG Inc. must provide prompt notification of any significant events affecting compliance during the exception period.
• The Nasdaq Listing and Hearing Review Council may review the Panel's decision within 45 calendar days.

Key Dates

Recommendation

While CIMG Inc. avoided immediate delisting, the conditional nature of its continued listing and the tight deadlines for compliance with the Periodic Filing and Equity Rules introduce significant uncertainty. The reliance on 'current and future capital raises' suggests ongoing financial challenges and potential dilution. Investors should hold and closely monitor the company's progress towards meeting the September 30, 2025, deadlines and the success of its capital raising efforts before making further investment decisions. The potential for a review by the Nasdaq Listing and Hearing Review Council also adds a layer of risk.

Keywords

CIMG Inc., Nasdaq, Listing Compliance, Delisting Risk, 8-K Filing, Corporate Governance, Capital Raise, Equity Rule, Periodic Filing Rule, SEC Filing